Cargando…

Immunological Features of Respiratory Syncytial Virus-Caused Pneumonia—Implications for Vaccine Design

The human respiratory syncytial virus (hRSV) is the causative agent for high rates of hospitalizations due to viral bronchiolitis and pneumonia worldwide. Such a disease is characterized by an infection of epithelial cells of the distal airways that leads to inflammation and subsequently to respirat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rey-Jurado, Emma, Kalergis, Alexis M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372572/ https://www.ncbi.nlm.nih.gov/pubmed/28273842 http://dx.doi.org/10.3390/ijms18030556

Ejemplares similares

Respiratory Syncytial Virus Vaccines: A Review of the Candidates and the Approved Vaccines
por: Topalidou, Xanthippi, et al.
Publicado: (2023)

Modulation of Host Immunity by Human Respiratory Syncytial Virus Virulence Factors: A Synergic Inhibition of Both Innate and Adaptive Immunity
por: Canedo-Marroquín, Gisela, et al.
Publicado: (2017)

Potential Neurocognitive Symptoms Due to Respiratory Syncytial Virus Infection
por: Andrade, Catalina A., et al.
Publicado: (2021)

Current Animal Models for Understanding the Pathology Caused by the Respiratory Syncytial Virus
por: Altamirano-Lagos, María José, et al.
Publicado: (2019)

A Recombinant BCG Vaccine Is Safe and Immunogenic in Neonatal Calves and Reduces the Clinical Disease Caused by the Respiratory Syncytial Virus
por: Díaz, Fabián E., et al.
Publicado: (2021)

Bacterial and Viral Coinfections with the Human Respiratory Syncytial Virus
por: Pacheco, Gaspar A., et al.
Publicado: (2021)

Contribution of Resident Memory CD8(+) T Cells to Protective Immunity against Respiratory Syncytial Virus and Their Impact on Vaccine Design
por: Retamal-Díaz, Angello, et al.
Publicado: (2019)

Host Components Contributing to Respiratory Syncytial Virus Pathogenesis
por: Carvajal, Jonatan J., et al.
Publicado: (2019)

Antibody development for preventing the human respiratory syncytial virus pathology
por: Soto, Jorge A., et al.
Publicado: (2020)

Functional Impairment of Mononuclear Phagocyte System by the Human Respiratory Syncytial Virus
por: Bohmwald, Karen, et al.
Publicado: (2017)

New Developments and Challenges in Antibody-Based Therapies for the Respiratory Syncytial Virus
por: Diethelm-Varela, Benjamín, et al.
Publicado: (2023)

Severe respiratory disease caused by human respiratory syncytial virus impairs language learning during early infancy
por: Peña, Marcela, et al.
Publicado: (2020)

Contribution of Fcγ Receptor-Mediated Immunity to the Pathogenesis Caused by the Human Respiratory Syncytial Virus
por: Acevedo, Orlando A., et al.
Publicado: (2019)

Safety and immunogenicity evaluation of recombinant BCG vaccine against respiratory syncytial virus in a randomized, double-blind, placebo-controlled phase I clinical trial
por: Abarca, Katia, et al.
Publicado: (2020)

Contribution of NKT cells to the immune response and pathogenesis triggered by respiratory viruses
por: Rey-Jurado, Emma, et al.
Publicado: (2020)

Influence of Pneumococcal Vaccines and Respiratory Syncytial Virus on Alveolar Pneumonia, Israel
por: Weinberger, Daniel M., et al.
Publicado: (2013)

Immunoproteomic Lessons for Human Respiratory Syncytial Virus Vaccine Design
por: López, Daniel, et al.
Publicado: (2019)

Role of Respiratory Syncytial Virus in Pediatric Pneumonia
por: Bianchini, Sonia, et al.
Publicado: (2020)

Contribution of Cytokines to Tissue Damage During Human Respiratory Syncytial Virus Infection
por: Bohmwald, Karen, et al.
Publicado: (2019)

Respiratory syncytial virus: promising progress against a leading cause of pneumonia
por: Ginsburg, Amy Sarah, et al.
Publicado: (2021)

Characterization of the humoral and cellular immunity induced by a recombinant BCG vaccine for the respiratory syncytial virus in healthy adults
por: Pacheco, Gaspar A., et al.
Publicado: (2023)

TCR Repertoire Characterization for T Cells Expanded in Response to hRSV Infection in Mice Immunized with a Recombinant BCG Vaccine
por: Rey-Jurado, Emma, et al.
Publicado: (2020)

Bovine Respiratory Syncytial Virus (BRSV) Pneumonia in Beef Calf Herds Despite Vaccination
por: Larsen, LE, et al.
Publicado: (2001)

Functional Features of the Respiratory Syncytial Virus G Protein
por: Anderson, Larry J., et al.
Publicado: (2021)

Challenges and Opportunities for Respiratory Syncytial Virus Vaccines
por: Graham, Barney S., et al.
Publicado: (2013)

The road to approved vaccines for respiratory syncytial virus
por: Ruckwardt, Tracy J.
Publicado: (2023)

Efficacy and safety of interferon on neonates with respiratory syncytial virus pneumonia
por: He, Lingyun, et al.
Publicado: (2020)

Microorganisms associated with respiratory syncytial virus pneumonia in the adult population
por: Jeannoël, M., et al.
Publicado: (2018)

Prevalence and clinical features of respiratory syncytial virus in children hospitalized for community-acquired pneumonia in northern Brazil
por: Lamarão, Letícia Martins, et al.
Publicado: (2012)

Common Features of Enveloped Viruses and Implications for Immunogen Design for Next-Generation Vaccines
por: Rey, Felix A., et al.
Publicado: (2018)

Effect of inactivated Streptococcus pneumoniae as non-pathogenic particles on the severity of pneumonia caused by respiratory syncytial virus infection in mice
por: Miyauchi, Aki, et al.
Publicado: (2019)

Recombinant BCG Vaccines Reduce Pneumovirus-Caused Airway Pathology by Inducing Protective Humoral Immunity
por: Soto, Jorge A., et al.
Publicado: (2018)

Increased Heme Oxygenase 1 Expression upon a Primary Exposure to the Respiratory Syncytial Virus and a Secondary Mycobacterium bovis Infection
por: Canedo-Marroquín, Gisela, et al.
Publicado: (2022)

Respiratory Syncytial Virus
por: Fraire, Armando E., et al.
Publicado: (2013)

Respiratory syncytial virus
por: Ruuskanen, Olli, et al.
Publicado: (1993)

Respiratory syncytial virus
por: Munoz, Flor M., et al.
Publicado: (2020)

Respiratory Syncytial Virus: Current Progress in Vaccine Development
por: Rudraraju, Rajeev, et al.
Publicado: (2013)

Developing Vaccines against Respiratory Syncytial Virus Infection
por: Chang, Jun
Publicado: (2011)

Fail-Fast in Respiratory Syncytial Virus Vaccine Development
por: Besteman, Sjanna B., et al.
Publicado: (2019)

Original Antigenic Sin and Respiratory Syncytial Virus Vaccines
por: Tripp, Ralph A., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_61j7rfra1pb7evh52q1hj51tnf